NEW YORK, Feb. 25, 2023 (GLOBE NEWSWIRE) —

Vascular Biogenics Ltd. VBLT

Lifshitz Law PLLC announces an investigation into a possible breach of fiduciary duties related to the merger of VBLT and Notable Labs, Inc. Post-merger, Notable shareholders are expected to own approximately 76% and Vascular shareholders are expected to own approximately 24% of the combined company.

If you are a VBLT investor and would like more information about our investigation, please fill out Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516) 493-9780 or by email info@lifshitzlaw.com.

Horizon Technology Finance Corporation HRZN

Lifshitz Law PLLC announces an investigation into a possible breach of fiduciary duties in connection with the sale of HRZN’s investment advisor, Horizon Technology Finance Management LLC, to a subsidiary of Monroe Capital LLC.

If you are an HRZN investor and would like more information about our research, please fill out Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516) 493-9780 or by email info@lifshitzlaw.com.

Infinity Pharmaceuticals, Inc. INFI

Lifshitz Law PLLC Announces Investigation into a Possible Breach of Fiduciary Duties in Connection with the INFI and MEI Pharma, Inc. Merger. Post-merger, pre-merger Infinity shareholders are expected to own approximately 42.0% of the combined company’s outstanding equity.

If you are an INFI investor and would like additional information about our investigation, please fill out Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516) 493-9780 or by email info@lifshitzlaw.com.

MEI Pharma, Inc. MEIP

Lifshitz Law PLLC announces an investigation into a possible breach of fiduciary duties in connection with the merger of MEIP and Infinity Pharmaceuticals, Inc. Post-merger, pre-merger MEIP shareholders are expected to own approximately 58.0% of the outstanding equity of…